Dana-Farber Cancer Institute shared a post on LinkedIn:
“Dana-Farber/Boston Children’s (Boston Children’s Hospital) is part of a multi-center study that received the Alex’s Lemonade Stand Foundation Crazy 8 Award for their research on early detection and innovative treatments for children predisposed to cancer.
This $5 million award will support a 4-year project, planned in collaboration with investigators in the Department of Newborn Medicine at Mass General Brigham and researchers at Baylor College of Medicine.
Lisa Diller MD, Vice Chair of the Department of Pediatric Oncology at Dana-Farber Cancer Institute and a pediatric oncologist in the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, and her colleagues will evaluate the promise of an expanding newborn blood testing to screen for several genetic cancer predisposition syndromes.
“Over the past decade we have been able to determine that as many as 10% of young children who develop cancer have an underlying genetic predisposition to the disease.
If we know who is at risk, we can intervene and find cancers early or even learn how to prevent them. – Lisa Diller”
More posts featuring Dana-Farber Cancer Institute on OncoDaily.